2 options
FDA's role in the evaluation of Avandia's safety : hearing before the Committee on Oversight and Government Reform, House of Representatives, One Hundred Tenth Congress, first session, June 6, 2007.
- Format:
- Book
- Government document
- Author/Creator:
- United States. Congress. House. Committee on Oversight and Government Reform
- Language:
- English
- Subjects (All):
- United States. Food and Drug Administration.
- United States.
- Rosiglitazone--Side effects.
- Rosiglitazone.
- Diabetes--Chemotherapy.
- Diabetes.
- Drugs--United States--Testing.
- Drugs.
- Drugs--Testing.
- Physical Description:
- iii, 138 pages : digital, PDF file
- Place of Publication:
- Washington : U.S. G.P.O., 2009.
- Notes:
- Title from title screen (viewed on Mar. 20, 2009).
- Paper version available for sale by the Supt. of Docs., U.S.G.P.O.
- Includes bibliographical references (page 23).
- "Serial no. 110-76."
- Other Format:
- United States. Congress. House. Committee on Oversight and Government Reform. FDA's role in the evaluation of Avandia's safety
- OCLC:
- 316525251
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.